These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19011510)

  • 1. STAT5 contributes to antiapoptosis in melanoma.
    Hassel JC; Winnemöller D; Schartl M; Wellbrock C
    Melanoma Res; 2008 Dec; 18(6):378-85. PubMed ID: 19011510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases.
    Mirmohammadsadegh A; Hassan M; Bardenheuer W; Marini A; Gustrau A; Nambiar S; Tannapfel A; Bojar H; Ruzicka T; Hengge UR
    J Invest Dermatol; 2006 Oct; 126(10):2272-80. PubMed ID: 16741510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase.
    Morcinek JC; Weisser C; Geissinger E; Schartl M; Wellbrock C
    Oncogene; 2002 Mar; 21(11):1668-78. PubMed ID: 11896598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.
    Machiraju D; Moll I; Gebhardt C; Sucker A; Buder-Bakhaya K; Schadendorf D; Hassel JC
    Melanoma Res; 2018 Jun; 28(3):204-210. PubMed ID: 29485532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transducer and activator of transcription-5 mediates neuronal apoptosis induced by inhibition of Rac GTPase activity.
    Stankiewicz TR; Loucks FA; Schroeder EK; Nevalainen MT; Tyler KL; Aktories K; Bouchard RJ; Linseman DA
    J Biol Chem; 2012 May; 287(20):16835-48. PubMed ID: 22378792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
    Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
    Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway.
    Qian YH; Xiao Q; Chen H; Xu J
    Biochim Biophys Acta; 2009 May; 1793(5):764-71. PubMed ID: 19339209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT5 contributes to interferon resistance of melanoma cells.
    Wellbrock C; Weisser C; Hassel JC; Fischer P; Becker J; Vetter CS; Behrmann I; Kortylewski M; Heinrich PC; Schartl M
    Curr Biol; 2005 Sep; 15(18):1629-39. PubMed ID: 16169484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.
    Hu T; Zhang C; Tang Q; Su Y; Li B; Chen L; Zhang Z; Cai T; Zhu Y
    BMC Cancer; 2013 May; 13():251. PubMed ID: 23693134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucoxanthin induces human melanoma cytotoxicity by thwarting the JAK2/STAT3/BCL-xL signaling axis.
    Kuo MY; Dai WC; Chang JL; Chang JS; Lee TM; Chang CC
    Environ Toxicol; 2024 Jun; 39(6):3356-3366. PubMed ID: 38444163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling by the oncogenic receptor tyrosine kinase Xmrk leads to activation of STAT5 in Xiphophorus melanoma.
    Wellbrock C; Geissinger E; Gómez A; Fischer P; Friedrich K; Schartl M
    Oncogene; 1998 Jun; 16(23):3047-56. PubMed ID: 9662338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation.
    Fujinaka Y; Takane K; Yamashita H; Vasavada RC
    J Biol Chem; 2007 Oct; 282(42):30707-17. PubMed ID: 17728251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL-X
    Trisciuoglio D; Tupone MG; Desideri M; Di Martile M; Gabellini C; Buglioni S; Pallocca M; Alessandrini G; D'Aguanno S; Del Bufalo D
    Cell Death Dis; 2017 Dec; 8(12):3216. PubMed ID: 29238043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter.
    Latha K; Li M; Chumbalkar V; Gururaj A; Hwang Y; Dakeng S; Sawaya R; Aldape K; Cavenee WK; Bogler O; Furnari FB
    Int J Cancer; 2013 Feb; 132(3):509-20. PubMed ID: 22729867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective STAT1 activation associated with impaired IFN-γ production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
    Sim GC; Wu S; Jin L; Hwu P; Radvanyi LG
    Oncotarget; 2016 Jun; 7(24):36074-36091. PubMed ID: 27153543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
    Tong H; Ren Y; Zhang F; Jin J
    Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel indoloquinoline derivative, IQDMA, suppresses STAT5 phosphorylation and induces apoptosis in HL-60 cells.
    Chien CM; Yang SH; Lin KL; Chen YL; Chang LS; Lin SR
    Chem Biol Interact; 2008 Oct; 176(1):40-7. PubMed ID: 18638462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
    Jensen J; Galsgaard ED; Karlsen AE; Lee YC; Nielsen JH
    J Endocrinol; 2005 Oct; 187(1):25-36. PubMed ID: 16214938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.
    Kim C; Baek SH; Um JY; Shim BS; Ahn KS
    BMC Nephrol; 2016 Feb; 17():19. PubMed ID: 26911335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.